What is the maximum dose of vasopressin (Vasopressin) for inotropic support?

Maximum Dose of Vasopressin for Inotropic Support

The maximum dose of vasopressin for inotropic support in patients with vasodilatory shock is 0.03-0.04 units/minute, with higher doses up to 0.1 units/minute reserved only for salvage therapy in post-cardiotomy shock when other vasopressors have failed. 1, 2, 3

Dosing Guidelines for Vasopressin

Vasopressin is primarily used as a vasopressor rather than an inotrope, with the following dosing recommendations:

• Standard dosing range: 0.01-0.07 units/minute 2, 3
• FDA-approved indications:
  • Septic shock: 0.01-0.07 units/minute 3
  • Post-cardiotomy shock: 0.03-0.1 units/minute 3

Administration Protocol

1. Preparation: Dilute 20 units/mL with normal saline (0.9% sodium chloride) or 5% dextrose in water to either 0.1 units/mL or 1 unit/mL for intravenous administration 3
2. Administration route: Preferably via central venous access to avoid tissue necrosis from extravasation 1
3. Monitoring: Continuous arterial blood pressure monitoring is recommended 1

Clinical Application

Vasopressin is typically added as a second agent to norepinephrine rather than used as a primary inotropic agent:

• First-line vasopressor: Norepinephrine (0.05-0.1 μg/kg/min initially) 2, 1
• Addition of vasopressin: Can be added to norepinephrine with the intent of either raising MAP or decreasing norepinephrine dosage 2

Important Considerations

Mechanism of Action

Vasopressin causes vasoconstriction by binding to V1 receptors on vascular smooth muscle, resulting in the release of intracellular calcium 3. Unlike true inotropes, it primarily increases systemic vascular resistance rather than directly enhancing cardiac contractility.

Cautions

• Vasopressin tends to decrease heart rate and cardiac output 3
• Can worsen cardiac function in some patients 3
• May cause reversible diabetes insipidus 3
• Common adverse reactions include decreased cardiac output, bradycardia, tachyarrhythmias, hyponatremia, and ischemia (coronary, mesenteric, skin, digital) 3

Discontinuation Strategy

When discontinuing vasopressors, evidence suggests that vasopressin should not be discontinued before norepinephrine, as this approach is associated with increased risk of hemodynamic instability 4.

Special Situations

For refractory hypotension, the Surviving Sepsis Campaign guidelines specifically state that "vasopressin doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy (failure to achieve adequate MAP with other vasopressor agents)" 2.

In clinical practice, exceeding the maximum recommended dose of 0.03-0.04 units/minute is generally not advised except in extreme circumstances of refractory shock, as higher doses have not been well-studied and may increase the risk of adverse effects without clear benefit to mortality 5.